CORRIGENDUM
In Vitro Inhibition of Staphylococcus aureus subsp. aureus (ATCC® 6538™) by Artemether-Lumefantrine Tablets: A Comparative Study of Three Dosage Strengths
Opoku Solomon1, *, Nyanor Isaac2
Article Information
Identifiers and Pagination:
Year: 2019Volume: 13
First Page: 67
Last Page: 67
Publisher ID: TOMICROJ-13-67
DOI: 10.2174/1874285801913010067
Article History:
Electronic publication date: 13/03/2019Collection year: 2019
open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: (https://creativecommons.org/licenses/by/4.0/legalcode). This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
In Vitro Inhibition of Staphylococcus aureus subsp. aureus (ATCC® 6538™) by Artemether-Lumefantrine Tablets: A Comparative Study of Three Dosage Strengths
The Open Microbiology Journal, 2018, 12: 397-403.
1- The correct word in running title in header is mentioned below:
aureus subsp.
The original word in running title in header was:
Aureus subsp.
2- The following unnecessary text was removed from the page number 400 & 401.
- This table is modified from Clinical and Laboratory Standards Institute. (2016). Performance standards for antimicrobial susceptibility testing; 26th ed. CLSI M100S. Clinical and Laboratory Standards Institute, Wayne, PA.
- These are footnote texts for Tables 1 and 2. Should be cut and pasted at the appropriate places.